Chadwick Jeremy G 4
4 · Kymera Therapeutics, Inc. · Filed May 27, 2026
Research Summary
AI-generated summary of this filing
Kymera (KYMR) COO Jeremy G. Chadwick Sells Shares
What Happened
- Jeremy G. Chadwick, Chief Operating Officer of Kymera Therapeutics (KYMR), disposed of a total of 17,184 shares in multiple open-market sales on May 26–27, 2026, generating approximately $1,373,290 in gross proceeds.
- Individual transactions reported: 3,730 @ $78.36 ($292,271); 324 @ $79.17 ($25,651); 3,800 @ $79.39 ($301,691); 4,500 @ $80.02 ($360,111); 551 @ $80.71 ($44,470); 3,679 @ $81.50 ($299,850); 600 @ $82.08 ($49,246). Overall sale prices reported as weighted averages across multiple trades, with per-trade ranges provided in the filing.
Key Details
- Transaction dates: May 26–27, 2026 (filed with the SEC on May 27, 2026).
- Total shares sold: 17,184; total gross proceeds: ≈ $1,373,290.
- Price range across transactions: approximately $77.99 to $82.15 per share (weighted-average ranges disclosed in footnotes).
- Notable footnotes: some sales were automatic to cover tax withholding obligations; some sales were executed pursuant to a Rule 10b5-1 trading plan (dated Dec 10, 2025); several entries report weighted-average prices across multiple trades and disclose price ranges.
- Shares owned after the transactions: not specified in the information provided.
- Timeliness: Filing date (May 27, 2026) follows the trades on May 26–27 and appears to be timely (no late-filing flag noted).
Context
- The filing codes indicate these were sales (S). Footnotes show a mix of mandatory tax-withholding dispositions and trades under a pre-established 10b5-1 plan — both are common, routine ways executives reduce share balances and manage tax obligations.
- For retail investors: purchases or new awards can be more indicative of insider confidence than routine sell-to-cover or plan-driven sales. This report documents disposals, not an acquisition or exercise followed by a hold.
Insider Transaction Report
Form 4
Chadwick Jeremy G
Chief Operating Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-05-26$78.36/sh−3,730$292,271→ 57,472 total - Sale
Common Stock
[F1]2026-05-26$79.17/sh−324$25,651→ 57,148 total - Sale
Common Stock
[F3][F4]2026-05-26$79.39/sh−3,800$301,691→ 53,348 total - Sale
Common Stock
[F3][F5]2026-05-26$80.02/sh−4,500$360,111→ 48,848 total - Sale
Common Stock
[F3][F6]2026-05-26$80.71/sh−551$44,470→ 48,297 total - Sale
Common Stock
[F3][F7]2026-05-27$81.50/sh−3,679$299,850→ 44,618 total - Sale
Common Stock
[F3][F8]2026-05-27$82.08/sh−600$49,246→ 44,018 total
Footnotes (8)
- [F1]Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not in the discretion of the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.99 to $78.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.66 to $79.655, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.66 to $80.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.70 to $80.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.985 to $81.94, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.99 to $82.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact|2026-05-27